Sponsors (11)
The bill would expand and standardize coverage of clinician‑prescribed therapeutic foods and oral specialty formulas—improving access and preventing invasive procedures for many vulnerable patients—while increasing public and private health spending and creating administrative and definitional challenges for payers and states.
Medicare beneficiaries, Medicaid/CHIP enrollees, federal employees, children, and people with inherited metabolic or malabsorption disorders would gain coverage or preserved access to clinician‑prescribed medically necessary oral specialty formulas and therapeutic foods, improving access to essential nutrition.
Patients (including infants) who can be managed with oral formulas would avoid unnecessary feeding tube placements, reducing risk of procedure‑related harms and preventing malnutrition and developmental complications for newborns.
By enabling appropriate oral therapy, the bill would reduce avoidable surgeries, hospital stays, and emergency visits — lowering downstream healthcare utilization and costs for hospitals, taxpayers, and families.
Taxpayers, federal and state budgets, and beneficiaries could face higher health spending as Medicare, Medicaid/CHIP, FEHB, and possibly private plans cover expensive medically necessary foods and related equipment.
States, insurers, and providers may incur administrative and budgetary burdens to implement or conform benefits (including potential new legislation, utilization management, and monitoring requirements).
Private insurers may come under pressure (per the sense of Congress) to expand coverage similarly, which could increase premiums or shift costs to enrollees and employers.
Based on analysis of 3 sections of legislative text.
Adds medically necessary foods and related equipment as a Medicare benefit and defines eligible products, conditions, exclusions, and supervision requirements.
Introduced October 3, 2025 by James P. McGovern · Last progress October 3, 2025
Adds a new Medicare benefit category that covers clinician-prescribed "medically necessary food" and the equipment and supplies needed to administer it for patients whose ability to eat, digest, absorb, or metabolize ordinary foods is limited and for whom dietary changes alone are insufficient. The change defines eligible products (specialized formulas, modified low-protein foods, amino-acid preparations, vitamins when part of therapy, etc.), limits use to people under active medical supervision, and excludes general diet products, many diabetes or gluten-free marketed foods, and other items the Secretary may disallow. Implementation will require Medicare (CMS) to adopt definitions, coverage policies, and payment coding; the change mainly affects Medicare beneficiaries with inherited metabolic or digestive conditions, clinicians who manage them, suppliers of specialty formulas, and federal program budgets and administration.